Maimon Research

Maimon Research is a health technology assessment company that supports a new research agenda in claims for pharmaceutical products and devices. Where claims are submitted the new agenda insists that they are in a form that can be validated with the results subitted to formulary committees as part of ongoing disease area and therapeutic class reviews. This approach rejects guidelines for modeling that have no possibility of generating testable outcomes. This includes groups such as the PBAC, ISPOR, NICE, CADTH and AMCP. The company can offer consulting support for claims and formulary submissions, building models to support testable claims, creating validation protocols, validating claims through access to 'big data' and presenting results to formulary committees.